Thoughts of daphne zohar on businesses

THE SECRET AND EVERYTHING? Another area Zohar, Weissman and Schilberg stressed was strong IP (intellectual property) protection. It’s a bad move to publish findings before locking down commercially-driven IP. Also, IP not covering key areas (such as the international market) isn’t attractive to investors, and will only create problems in the long run. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>http://www.fiercebiotech.com/story/funding-biotech-start/2008-03-17